Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact on society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards.

... Responsibility

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

... Requests for funding

What we have to offer – and what we seek

We are known for our expertise in pain. Strong partnerships are fundamental to our success and our track record in this area is exceptional. Many of our partners have been working with us for several years – and are keen to extend our business relationship into the future.

We put this success down to good communication, excellent compliance standards, strong business development and access to attractive markets, as well as our integrated strategic Alliance Management and Integration Management Office. Our partners value Grünenthal’s state-of-the-art production facilities and high-quality products. We strengthen and develop our core markets in Europe and Latin America through traditional deal structures, such as acquisitions, asset deals, in-licensing, commercialisation and distribution deals and are also open to any other innovative form of deal-making.

Europe

In this region, we focus on well established brands that closely fit to our existing commercial footprint – independent of specific therapeutic areas or indications. In addition, as a global leader in pain R&D, pain is our core business. We are interested in partnerships for late-stage (phII-III) pain development projects.

This includes:

Peripheral neuropathic pain
Chronic post-surgical pain
Chronic low back pain
Osteoarthritis
Migraine

North America

We are building a preeminent pain management company to address the US market. We are open to working with parties to help build our ecosystem of healthcare to provide patients with comprehensive pain management, based on three pillars: product, platform and pipeline.

Latin America

Grünenthal is one of the top companies in all key markets of that region. We focus on products in late-stage clinical development that are ready to be filed or launched, as well as marketing established products and portfolios or taking over local representations of existing companies and their portfolios within our therapeutic key areas or areas that fit to our commercial footprint.

This includes treatments for:

Pain
CNS
Women’s health
and adjacent therapies outside of these therapeutic areas, that are prescribed by the same target audience.

Out-Licensing

We are actively seeking new opportunities to collaborate, from co-development and co-marketing through to co-promotion and licensing. Grünenthal is particularly interested in partnering in countries and regions where we have not yet established a presence through own subsidiaries, such as Canada, the Middle East, and Asia – especially Japan and China – and Africa.

Research and Development

As a global leader in pain, our mission is to find breakthrough solutions for our patients. In order to achieve this we are combining our deep understanding of pain and proven experience in developing innovative pain treatments with novel, innovative and impactful ideas of our partners. We are seeking R&D collaborations that focus on pain indications and, independent of their development stage and modality, have the potential to make a real difference to patients.

Get in touch

We’re keen to hear new ideas and discover assets that are relevant to our business. If you’re interested in partnering with us, get in touch.

M-N/A-IE-01-24-0005 - January 2024